RxDoctor Payments Data

Jeffrey Stern, MD

Transplant Surgery · New York, NYNPI 1114364056

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,730 of the $3,629 with a category attached, or 75.2%. 6 manufacturers reported payments, led by Intuitive Surgical at 50.5% of the total. Reporting peaked in 2024 at $1,551 and has fallen 87.5% since, to $194 in 2025.

$3,629in general payments, 2019–2025

Across 22 payments — averaging $164.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Transmedics, Inc.$1K
  • Medtronic$219
  • Paragonix Technologies, Inc.$190
  • Veloxis Pharmaceuticals, Inc.$145
  • Bayer$120
$47,688in research payments, 2019–2025

Across 8 payments — averaging $5961.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$47K
  • United Therapeutics Corporation$556

What the payments were for

  • Travel & lodging$2,73075%
  • Food & beverage$89925%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,629 in reported general payments places this provider in the 60th percentile of 72 transplant surgery providers in New York.

See all transplant surgery providers in New York

Medicare billing

Part B allowed, 2024
$60,485
Medicare patients
51
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →